Alexza Pharmaceuticals, Inc. (ALXA) Posts Q2 Loss of 34c/Share
Tweet
Share
E-mailGet Alerts ALXA Hot Sheet
Price: $0.92 --0%
Financial Fact:
General and administrative: 1.81M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
General and administrative: 1.81M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) reported Q2 EPS of ($0.34), $0.33 better than the analyst estimate of ($0.67). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $2.24 million.
For earnings history and earnings-related data on Alexza Pharmaceuticals, Inc. (ALXA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
